Search
Enhancing clinical research through genetic analysis: Program
| Talk Title | Speaker | Abstract | Duration |
|---|---|---|---|
| Fragment analysis and Sanger sequencing: Useful molecular approach in immunohematology | Dr. Ho Eun Chang | Immunohematology has been the core of transfusion medicine. Hemagglutination, the original method to test for blood group antigens and antibodies, is the gold standard test in the immunohematology laboratory. However, molecular approaches are also being applied to clinical situations and known as an effective solution to complement the limitations of hemagglutination method. This presentation shares how molecular approaches (fragment analysis and Sanger sequencing) can help solving clinical issues for human erythrocyte antigens, human neutrophil antigens, and human platelet antigens. | 30 minutes |
| Sanger sequencing and Fragment analysis in Cancer Precision Medicine: An Experience with the Applied Biosystems SeqStudio Flex Genetic Analyzer | Dr. Prerana Jha | Tumor genetic profiling is fundamental and is extensively used in clinical settings for cancer diagnosis, treatment decision and prognostic determination. Need of successful identification and characterization of actionable mutation is increasing owing to robust sequencing techniques and advancements in precision oncology. Sanger sequencing and fragment length polymorphism are still the full proof technology for accurately stating the presence alterations in clinical setting and they hold great value for NGS(next generation sequencing) orthogonal validation, research and discovery of novel mutants. The SeqStudio Flex Genetic Analyzer offers higher level flexibility to multiplex and perform multiplexed multiple marker fragment analysis with improved data quality. We look forward to sharing our wonderful experience of journey from 3500xL to SeqStudio Flex Genetic Analyzer in the age of NGS, advanced precision medicine cancer diagnostics and research. | 30 minutes |
| The versatility of MLPA®: from hereditary disorder to tumour profiling | Dr. Julia Falschlunger | MRC-Holland is the inventor and manufacturer of MLPA®, the gold standard for the detection of DNA copy numbers and methylation patterns associated with disease. MLPA is used around the world to study hereditary disorders and tumour profiling. Together with MLPA, MRC Holland offers Melt Assay for SMA Newborn Screen, and digitalMLPA™, the bridge between MLPA and NGS. MRC Holland offers hundreds of different assays, used on millions of samples every year. In order to showcase the versatility of our technology, the following products will be discussed in detail: P008 PMS2, P021 SMA and ME028 PWS/AS. | 30 minutes |
For Research Use Only. Not for use in diagnostic procedures.
© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified
View our Privacy Policy .